company background image
DIA logo

DiaSorin BIT:DIA Voorraadrapport

Laatste prijs

€109.50

Marktkapitalisatie

€5.8b

7D

9.9%

1Y

29.1%

Bijgewerkt

08 Nov, 2024

Gegevens

Financiële gegevens bedrijf +

DiaSorin S.p.A.

BIT:DIA Voorraadrapport

Marktkapitalisatie: €5.8b

DIA Overzicht aandelen

DiaSorin S.p.A. houdt zich bezig met de ontwikkeling, productie en distributie van testkits voor immunodiagnostiek en moleculaire diagnostiek in Europa, Afrika, Noord-Amerika, Centraal- en Zuid-Amerika, Azië-Pacific en China.

Over het bedrijf

Beloningen

De winst zal naar verwachting met 13.1% per jaar groeien

Risicoanalyse

Aanzienlijke insider-verkoop in de afgelopen 3 maanden

DiaSorin S.p.A. Concurrenten

EL.En

BIT:ELN

€820.7m

Amplifon

BIT:AMP

€5.5b

I.M.D. International Medical Devices

BIT:IMD

€26.8m

Jiangsu Yuyue Medical Equipment & Supply

SZSE:002223

CN¥37.0b

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor DiaSorin
Historische aandelenkoersen
Huidige aandelenkoers€109.50
52 Week Hoogtepunt€112.35
52 Week Laag€82.72
Bèta0.19
11 maand verandering6.26%
3 maanden verandering9.92%
1 Jaar Verandering29.10%
33 jaar verandering-41.76%
5 jaar verandering-1.08%
Verandering sinds IPO784.49%

Recent nieuws en updates

DiaSorin S.p.A. (BIT:DIA) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Nov 08
DiaSorin S.p.A. (BIT:DIA) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Recent updates

DiaSorin S.p.A. (BIT:DIA) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Nov 08
DiaSorin S.p.A. (BIT:DIA) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

DiaSorin S.p.A. (BIT:DIA) Investors Are Less Pessimistic Than Expected

Aug 23
DiaSorin S.p.A. (BIT:DIA) Investors Are Less Pessimistic Than Expected

DiaSorin S.p.A. (BIT:DIA) Just Released Its Interim Results And Analysts Are Updating Their Estimates

Aug 01
DiaSorin S.p.A. (BIT:DIA) Just Released Its Interim Results And Analysts Are Updating Their Estimates

We Think DiaSorin (BIT:DIA) Can Stay On Top Of Its Debt

Jul 16
We Think DiaSorin (BIT:DIA) Can Stay On Top Of Its Debt

DiaSorin's (BIT:DIA) Dividend Will Be Increased To €1.15

Apr 09
DiaSorin's (BIT:DIA) Dividend Will Be Increased To €1.15

DiaSorin (BIT:DIA) Is Paying Out A Larger Dividend Than Last Year

Mar 25
DiaSorin (BIT:DIA) Is Paying Out A Larger Dividend Than Last Year

DiaSorin S.p.A. (BIT:DIA) Just Released Its Yearly Results And Analysts Are Updating Their Estimates

Mar 20
DiaSorin S.p.A. (BIT:DIA) Just Released Its Yearly Results And Analysts Are Updating Their Estimates

DiaSorin S.p.A.'s (BIT:DIA) Intrinsic Value Is Potentially 19% Below Its Share Price

Feb 17
DiaSorin S.p.A.'s (BIT:DIA) Intrinsic Value Is Potentially 19% Below Its Share Price

Is DiaSorin (BIT:DIA) Using Too Much Debt?

Jan 25
Is DiaSorin (BIT:DIA) Using Too Much Debt?

Some May Be Optimistic About DiaSorin's (BIT:DIA) Earnings

Nov 11
Some May Be Optimistic About DiaSorin's (BIT:DIA) Earnings

DiaSorin S.p.A.'s (BIT:DIA) Intrinsic Value Is Potentially 24% Below Its Share Price

Oct 11
DiaSorin S.p.A.'s (BIT:DIA) Intrinsic Value Is Potentially 24% Below Its Share Price

Is DiaSorin (BIT:DIA) A Risky Investment?

Sep 19
Is DiaSorin (BIT:DIA) A Risky Investment?

Does DiaSorin (BIT:DIA) Have A Healthy Balance Sheet?

May 01
Does DiaSorin (BIT:DIA) Have A Healthy Balance Sheet?

DiaSorin (BIT:DIA) Is Increasing Its Dividend To €1.10

Apr 02
DiaSorin (BIT:DIA) Is Increasing Its Dividend To €1.10

Does DiaSorin (BIT:DIA) Have A Healthy Balance Sheet?

Jan 07
Does DiaSorin (BIT:DIA) Have A Healthy Balance Sheet?

These 4 Measures Indicate That DiaSorin (BIT:DIA) Is Using Debt Reasonably Well

Sep 13
These 4 Measures Indicate That DiaSorin (BIT:DIA) Is Using Debt Reasonably Well

Are DiaSorin S.p.A. (BIT:DIA) Investors Paying Above The Intrinsic Value?

Aug 17
Are DiaSorin S.p.A. (BIT:DIA) Investors Paying Above The Intrinsic Value?

DiaSorin (BIT:DIA) Has A Pretty Healthy Balance Sheet

Jun 14
DiaSorin (BIT:DIA) Has A Pretty Healthy Balance Sheet

DiaSorin (BIT:DIA) Will Pay A Larger Dividend Than Last Year At €1.05

May 19
DiaSorin (BIT:DIA) Will Pay A Larger Dividend Than Last Year At €1.05

DiaSorin's (BIT:DIA) Shareholders Will Receive A Bigger Dividend Than Last Year

May 03
DiaSorin's (BIT:DIA) Shareholders Will Receive A Bigger Dividend Than Last Year

Calculating The Fair Value Of DiaSorin S.p.A. (BIT:DIA)

May 01
Calculating The Fair Value Of DiaSorin S.p.A. (BIT:DIA)

DiaSorin (BIT:DIA) Is Paying Out A Larger Dividend Than Last Year

Apr 13
DiaSorin (BIT:DIA) Is Paying Out A Larger Dividend Than Last Year

DiaSorin (BIT:DIA) Is Increasing Its Dividend To €1.05

Mar 21
DiaSorin (BIT:DIA) Is Increasing Its Dividend To €1.05

Here's Why I Think DiaSorin (BIT:DIA) Is An Interesting Stock

Mar 02
Here's Why I Think DiaSorin (BIT:DIA) Is An Interesting Stock

Is DiaSorin S.p.A. (BIT:DIA) Expensive For A Reason? A Look At Its Intrinsic Value

Jan 19
Is DiaSorin S.p.A. (BIT:DIA) Expensive For A Reason? A Look At Its Intrinsic Value

Is DiaSorin (BIT:DIA) Using Too Much Debt?

Dec 04
Is DiaSorin (BIT:DIA) Using Too Much Debt?

Does DiaSorin (BIT:DIA) Deserve A Spot On Your Watchlist?

Oct 18
Does DiaSorin (BIT:DIA) Deserve A Spot On Your Watchlist?

Is DiaSorin (BIT:DIA) A Risky Investment?

Aug 23
Is DiaSorin (BIT:DIA) A Risky Investment?

Industry Analysts Just Upgraded Their DiaSorin S.p.A. (BIT:DIA) Revenue Forecasts By 12%

Jul 15
Industry Analysts Just Upgraded Their DiaSorin S.p.A. (BIT:DIA) Revenue Forecasts By 12%

Here's Why I Think DiaSorin (BIT:DIA) Might Deserve Your Attention Today

Jul 13
Here's Why I Think DiaSorin (BIT:DIA) Might Deserve Your Attention Today

Does DiaSorin (BIT:DIA) Deserve A Spot On Your Watchlist?

Apr 02
Does DiaSorin (BIT:DIA) Deserve A Spot On Your Watchlist?

DiaSorin S.p.A.'s (BIT:DIA) 0.7% Dividend Yield Looks Pretty Interesting

Mar 15
DiaSorin S.p.A.'s (BIT:DIA) 0.7% Dividend Yield Looks Pretty Interesting

Are Institutions Heavily Invested In DiaSorin S.p.A.'s (BIT:DIA) Shares?

Feb 25
Are Institutions Heavily Invested In DiaSorin S.p.A.'s (BIT:DIA) Shares?

Returns On Capital - An Important Metric For DiaSorin (BIT:DIA)

Feb 04
Returns On Capital - An Important Metric For DiaSorin (BIT:DIA)

Did You Participate In Any Of DiaSorin's (BIT:DIA) Incredible 311% Return?

Jan 14
Did You Participate In Any Of DiaSorin's (BIT:DIA) Incredible 311% Return?

Is Now The Time To Put DiaSorin (BIT:DIA) On Your Watchlist?

Dec 24
Is Now The Time To Put DiaSorin (BIT:DIA) On Your Watchlist?

Are Robust Financials Driving The Recent Rally In DiaSorin S.p.A.'s (BIT:DIA) Stock?

Dec 02
Are Robust Financials Driving The Recent Rally In DiaSorin S.p.A.'s (BIT:DIA) Stock?

Rendement voor aandeelhouders

DIAIT Medical EquipmentIT Markt
7D9.9%8.4%-1.4%
1Y29.1%25.2%15.8%

Rendement versus industrie: DIA overtrof de Italian Medical Equipment industrie, die het afgelopen jaar een rendement 25.2 % opleverde.

Rendement versus markt: DIA overtrof de Italian markt, die het afgelopen jaar een rendement opleverde van 15.8 %.

Prijsvolatiliteit

Is DIA's price volatile compared to industry and market?
DIA volatility
DIA Average Weekly Movement3.3%
Medical Equipment Industry Average Movement4.3%
Market Average Movement4.1%
10% most volatile stocks in IT Market7.0%
10% least volatile stocks in IT Market2.3%

Stabiele aandelenkoers: DIA heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 3% ) van DIA is het afgelopen jaar stabiel geweest.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
19683,186Carlo Rosadiasoringroup.com/en

DiaSorin S.p.A. houdt zich bezig met de ontwikkeling, productie en distributie van immunodiagnostische en moleculaire diagnostische testkits in Europa, Afrika, Noord-Amerika, Midden- en Zuid-Amerika, Azië-Pacific en China. Het bedrijf levert verschillende immunodiagnostische LIAISON platforms, waaronder LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL en LIAISON XL LAS. Het bedrijf biedt ook platforms voor moleculaire diagnostiek, waaronder LIAISON NES, een nieuw moleculair platform dat inspeelt op de groeiende trend van gedecentraliseerde diagnostiek; de ARIES- en ARIES M1-systemen; LIAISON MDX, een thermocycler met twee verbruikbare schijfopties; LIAISON MDX Plus; MAGPIX System; Luminex 100/200 System; VERIGENE System; en het LIAISON PLEX System.

DiaSorin S.p.A. Samenvatting

Hoe verhouden de winst en inkomsten van DiaSorin zich tot de beurswaarde?
DIA fundamentele statistieken
Marktkapitalisatie€5.84b
Inkomsten(TTM)€188.85m
Inkomsten(TTM)€1.18b

30.9x

Koers/Winstverhouding

5.0x

P/S-verhouding

Is DIA overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
DIA resultatenrekening (TTM)
Inkomsten€1.18b
Kosten van inkomsten€406.02m
Brutowinst€772.19m
Overige uitgaven€583.34m
Inkomsten€188.85m

Laatst gerapporteerde inkomsten

Sep 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)3.54
Brutomarge65.54%
Nettowinstmarge16.03%
Schuld/Eigen Vermogen Verhouding42.6%

Hoe presteerde DIA op de lange termijn?

Bekijk historische prestaties en vergelijking

Dividenden

1.1%

Huidig dividendrendement

38%

Uitbetalingsratio